We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights Meta Platforms, Eaton, The Cigna, Colgate-Palmolive and Parker-Hannifin
Read MoreHide Full Article
For Immediate Release
Chicago, IL – February 6, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Meta Platforms, Inc. (META - Free Report) , Eaton Corp. (ETN - Free Report) , The Cigna Group (CI - Free Report) , Colgate-Palmolive Co. (CL - Free Report) and Parker-Hannifin Corp. (PH - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Analyst Reports for Meta Platforms, Eaton and Cigna
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc., Eaton Corp. and The Cigna Group. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Meta Platforms shares have outperformed the Zacks Internet - Software industry over the past year (+155.3% vs. +65.4%), with the blockbuster December-quarter results adding to the stock's momentum. The company is benefiting from steady user growth across all regions, particularly Asia Pacific. Increased engagement for its offerings like Instagram, WhatsApp, Messenger and Facebook has been a major growth driver.
Meta Platforms’ is leveraging AI to recommend Reels content, which is driving traffic on Instagram and Facebook. Its innovative portfolio, which includes Threads, Reels and Llama 2, is likely to aid prospects.
However, challenging macroeconomic conditions remain a headwind for Meta’s advertising revenues, along with targeting and measurement headwinds due to Apple’s iOS changes. Slow monetization of Reels, along with mounting operating losses at Reality Labs, are concerns.
Shares of Eaton have outperformed the Zacks Manufacturing - Electronics industry over the past year (+69.4% vs. +28.4%). The company’s research and development are allowing it to develop new products to provide efficient power management solutions.
It will benefit from improving end-market conditions, increasing demand from the new AI data center and contributions from its organic assets. Eaton is expanding via acquisitions and its rising backlog shows demand for its products. Its strategy to manufacture in the region of its end market has helped it cut costs.
However, Eaton’s global operations expose it to unpredictable currency translation, cyber security threats, changes in tax rates and security breaches, which might impact operations. The shortage of raw materials and supplier insolvencies might impact production and operations.
Cigna shares have outperformed the Zacks Medical - HMOs industry over the past year (+14.3% vs. +7.7%). The company’s revenues have been increasing consistently for the past few years, driven by acquisitions, superior operating performance and a high-quality product portfolio. It expects adjusted revenues to jump 20% in 2024.
Value-enhancing divestitures will help it to focus on core growth areas. High membership on the back of a diversified portfolio, wide agent network and superior service are major positives. It reported strong Q4 results, driven by higher memberships. The company has been resorting to prudent capital deployment moves through share repurchases and dividend payments.
However, high leverage can affect its financial flexibility. Rising operating costs due to higher pharmacy and other service costs are a concern. As such, the stock warrants a cautious stance.
Other noteworthy reports we are featuring today include Colgate-Palmolive Co. and Parker-Hannifin Corp.
Why Haven’t You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights Meta Platforms, Eaton, The Cigna, Colgate-Palmolive and Parker-Hannifin
For Immediate Release
Chicago, IL – February 6, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Meta Platforms, Inc. (META - Free Report) , Eaton Corp. (ETN - Free Report) , The Cigna Group (CI - Free Report) , Colgate-Palmolive Co. (CL - Free Report) and Parker-Hannifin Corp. (PH - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Analyst Reports for Meta Platforms, Eaton and Cigna
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc., Eaton Corp. and The Cigna Group. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Meta Platforms shares have outperformed the Zacks Internet - Software industry over the past year (+155.3% vs. +65.4%), with the blockbuster December-quarter results adding to the stock's momentum. The company is benefiting from steady user growth across all regions, particularly Asia Pacific. Increased engagement for its offerings like Instagram, WhatsApp, Messenger and Facebook has been a major growth driver.
Meta Platforms’ is leveraging AI to recommend Reels content, which is driving traffic on Instagram and Facebook. Its innovative portfolio, which includes Threads, Reels and Llama 2, is likely to aid prospects.
However, challenging macroeconomic conditions remain a headwind for Meta’s advertising revenues, along with targeting and measurement headwinds due to Apple’s iOS changes. Slow monetization of Reels, along with mounting operating losses at Reality Labs, are concerns.
(You can read the full research report on Meta Platforms here >>>)
Shares of Eaton have outperformed the Zacks Manufacturing - Electronics industry over the past year (+69.4% vs. +28.4%). The company’s research and development are allowing it to develop new products to provide efficient power management solutions.
It will benefit from improving end-market conditions, increasing demand from the new AI data center and contributions from its organic assets. Eaton is expanding via acquisitions and its rising backlog shows demand for its products. Its strategy to manufacture in the region of its end market has helped it cut costs.
However, Eaton’s global operations expose it to unpredictable currency translation, cyber security threats, changes in tax rates and security breaches, which might impact operations. The shortage of raw materials and supplier insolvencies might impact production and operations.
(You can read the full research report on Eaton here >>>)
Cigna shares have outperformed the Zacks Medical - HMOs industry over the past year (+14.3% vs. +7.7%). The company’s revenues have been increasing consistently for the past few years, driven by acquisitions, superior operating performance and a high-quality product portfolio. It expects adjusted revenues to jump 20% in 2024.
Value-enhancing divestitures will help it to focus on core growth areas. High membership on the back of a diversified portfolio, wide agent network and superior service are major positives. It reported strong Q4 results, driven by higher memberships. The company has been resorting to prudent capital deployment moves through share repurchases and dividend payments.
However, high leverage can affect its financial flexibility. Rising operating costs due to higher pharmacy and other service costs are a concern. As such, the stock warrants a cautious stance.
(You can read the full research report on Cigna here >>>)
Other noteworthy reports we are featuring today include Colgate-Palmolive Co. and Parker-Hannifin Corp.
Why Haven’t You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.